Walleye Capital’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,080	Closed	-$25K	–	2369
2022 Q1	$25K	Sell	15,080 -11,502	-43%	-$19.1K	﹤0.01%	1854
2021 Q4	$64K	Buy	+26,582	New	+$64K	﹤0.01%	1697